Biotalys NV ( (DE:86C) ) has issued an update.
Biotalys has announced promising results from field trials of its second biofungicide, BioFun-6, which demonstrated excellent efficacy against Botrytis and powdery mildew in fruits and vegetables at significantly lower doses than its predecessor, EVOCA. This advancement highlights the potential of Biotalys’ AGROBODY technology to deliver cost-effective and sustainable crop protection solutions, positioning the company to capitalize on the growing biofungicide market, which is expected to reach over USD 17 billion by 2030.
More about Biotalys NV
Biotalys is an Agricultural Technology (AgTech) company based in Ghent, Belgium, specializing in the development of protein-based biocontrol solutions aimed at providing sustainable alternatives to conventional chemical pesticides. Founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology), Biotalys focuses on creating effective crop protection products using its novel AGROBODY technology platform. The company has been publicly listed on Euronext Brussels since July 2021.
YTD Price Performance: -10.46%
Average Trading Volume: 864
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: €113.2M
See more data about 86C stock on TipRanks’ Stock Analysis page.